KOREA PHARM & BIO 2027

KOREA PHARM & BIO, the Korea International Pharmaceutical & Bio-Pharma Exhibition, holds its 17th edition at KINTEX 2 in April 2027. Organised by Kyungyon Exhibition Corp. and AKEI-certified, it brings together pharmaceutical ingredient suppliers, biologics developers, outsourcing partners and service providers serving Korea's drug and bio-health industry.

Exhibit categories

The 2027 exhibit list is organised into eight zones:

• Pharmaceuticals and ingredients: APIs, finished dosage, intermediates, excipients
• Biologics and regenerative medicine: biosimilars, antibodies, vaccines, cell and gene therapy
• Drug discovery and R&D: AI drug discovery, omics, organoids, drug delivery
• CDMO and CRO outsourcing: CMO, preclinical and clinical trials, contract testing
• Regulatory and professional services: RA consulting, GMP and validation, IP
• Digital healthcare and diagnostics: DTx, AI diagnostics, IVD
• Health ingredients and nutraceuticals
• Government, research institutions, bio clusters and investors

Conferences and seminars

The programme lists the MFDS Pharmaceutical & Bio-Pharma Policy Seminar, the Pharm & Bio-health Business Development Strategy Forum, a Technology Transfer & IR Forum, the International Forum on Pharmaceutical & Bio-Pharma Business, a Data Integrity & LIMS Conference, biz-matching, a micro-needle convergence seminar and exhibitor new technology seminars.

Part of ICPI WEEK

The show runs alongside eight sister exhibitions organised by Kyungyon Exhibition Corp. / KY EXPOSITION CORP. at KINTEX: KOREA MAT, KOREA COLD CHAIN, KOREA DARK FACTORY, ESG PACK, KOREA CHEM and COPHEX in KINTEX 1, and CI KOREA, KOREA PHARM & BIO and KOREA LAB in KINTEX 2. The 2026 edition (31 March to 3 April) drew 1,455 exhibitors on 4,926 booths and 63,368 visitors from 49 countries, counting all concurrent shows.

Tickets & passes

• Online pre-registration — Free: Until 19 April 2027, 18:00; covers the nine concurrent shows
• Onsite admission — KRW 20,000